Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(24 sites)
United States
University of California, Davis Comprehensive Cancer Center, Sacramento, California UCLA Hematology/Oncology - Santa Monica, Santa Monica, California Research Site 117, Coral Gables, Florida D&H Cancer Research Center LLC, Margate, Florida Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida